Biotechnology News

March 23, 2012

SAN DIEGO--(BUSINESS WIRE)--PerkinElmer Launches Innovative Informatics Solutions at the American Chemical Society Spring 2012 National Meeting & Expo

March 23, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Partnered with Journeys Within Our Communities to provide access to clean drinking water for 1,000 people in Cambodia

March 23, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical announces key findings at ACC.12 – the 61st Annual Scientific Session and Expo of the American College of Cardiology.

March 23, 2012

BOSTON--(BUSINESS WIRE)--The second annual conference of the Pistoia Alliance on April 24, 2012, will feature several deliverables for NGS data management and analysis developed through precompetitive collaboration.

March 23, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) today announced that the U.S. Food and Drug Administration’s Gastrointestinal Drugs Advisory Committee will meet on May 31, 2012 to discuss the Company’s New Drug Application (...

March 23, 2012

NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics announced that data and acute results from its CorPath PRECISE Trial will be presented during a scientific presentation at ACC 2012.

March 23, 2012

MISGAV, Israel and SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue,...

March 23, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Mechanism of action data presented at the Society of Surgical Oncology Annual Meeting confirms that PV-10 therapy induces an immunologic response.

March 23, 2012

HORSHAM, Pa.--(BUSINESS WIRE)--ImpactRx, a Symphony Technology Group (STG) company, announced today that it has acquired AlphaDetail, Inc., a leader in global healthcare primary market research and influence network mapping.

March 23, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Prepares to Join the $3 Billion Fight Against Parkinson’s Disease

March 23, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica announces its partnership with NextDocs to deliver solutions that provide easier access to clinical trial information and decrease the timeline for FDA submissions.

March 23, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology announced today that it has filed a registration statement on Form S-1 with the SEC relating to a proposed underwritten public offering of $75 million of shares of its common stock

March 23, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Annual General Meeting will be held at 4 p.m. on Tuesday April 24, 2012, at Precise Biometrics (STO:PREC) premises, Scheelevägen 30 in Lund, Sweden. An agenda containing the matters that are...

March 23, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: The Nomination Committee of Meda AB (STO:MEDAA) proposes the election of Lars Westerberg as new board member. The committee also proposes re-election of Maria Carell, Peter Claesson, Peter von...

March 23, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hyperion Therapeutics, Inc. today announced that it has acquired worldwide rights to the investigational drug Ravicti™ (glycerol phenylbutyrate) from Ucyclyd Pharma, Inc., a wholly owned subsidiary of...

March 23, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics announces pricing of public offering and listing on NASDAQ.

March 22, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to...

March 22, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Accellent Inc. (the “Company” or “Accellent”), a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal fourth quarter ended December 31, 2011. Fourth Quarter 2011 Financial...

March 22, 2012

NEWARK, Del.--(BUSINESS WIRE)--SDIX (Nasdaq: SDIX), a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic and food safety applications, today reported financial results for...

March 22, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International (NYSE:BAX), will host a quarterly conference call to discuss its first quarter 2012 financial results on Thursday, April 19, 2012, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To...

March 22, 2012

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced a definitive agreement to acquire Newport Medical...

March 22, 2012

BROOKLINE, Mass.--(BUSINESS WIRE)--Lown Cardiovascular Research Foundation to Present Favorable Long Term Results in Coronary Patients Who Deferred Invasive Tests or Treatment; at Annual Meeting of American College of Cardiology

March 22, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) applauds the Senate on the passage of H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act. The JOBS Act, which passed the Senate by a vote of 73-26, contains several...

March 22, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Global collaboration and regulatory compliance is easier and more efficient with NextDocs solutions that address a broad range of demands on life sciences companies. We’re making it easier too.

March 22, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Evidence-Based Solution Selling® addresses the new sales paradigm rapidly emerging in Life Sciences SPI has integrated best practices from Solution Selling® and Evidence-Based Selling®

March 22, 2012

MISSION VIEJO, Calif.--(BUSINESS WIRE)--Joseph J. Flynn, President & CEO of AUXILIO, Inc. (AUXO.OB), the pioneer in Managed Print Services (MPS) for the health care industry, will be a featured speaker at the iHT2 Health IT Summit during a...

March 22, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) and BioTime’s subsidiary OncoCyte Corporation today provided a progress report on the development of PanC-DxTM, a novel diagnostic device developed at BioTime and OncoCyte to detect...

March 22, 2012

AUSTIN, Texas--(BUSINESS WIRE)--RNA Cleared by FDA Pre-analytical RNA Stabilization Device, RNA Retain, clinically validated and cGMP manufactured. RNA Later

March 22, 2012

CAESAREA, Israel--(BUSINESS WIRE)--Itamar-Medical will unveil its cardiovascular healthcare assessment platform, EndoPAT-MF, at the upcoming American College of Cardiology Conference in Chicago.

March 22, 2012

EXTON, Pa.--(BUSINESS WIRE)--Twelve months post-launch of KRYSTEXXA, surveyed rheumatologists appear to have high awareness of KRYSTEXXA and reserve it for chronic refractory gout patients

March 22, 2012

ST. LOUIS--(BUSINESS WIRE)--Mallinckrodt, the pharmaceuticals business of Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of its morphine sulfate oral solution for the relief of moderate-to-...

March 22, 2012

WASHINGTON--(BUSINESS WIRE)--BIO announces nominations are open for 4th annual Biotech Humanitarian Award. The Award will be given at the 2012 Biotechnology International Convention in Boston June 19-21

March 22, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Euthymics announced that it has initiated a Phase 1 clinical trial of EB-1020, a next-generation drug in development for treating adult ADHD, with low risk of drug abuse liability.

March 22, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the fourth quarter and year ended December 31, 2011.

March 22, 2012

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR), a developer of innovative surgical robots and complementary products, today announced that the company will host conference calls on Wednesday, March 28, 2012 to discuss fourth...

March 22, 2012

PARIS--(BUSINESS WIRE)--Exonhit announces 2011 financial results (decrease in net loss, repayment of debt, approximately 24 months of cash), highlights key points for 2011 and perspectives 2012.

March 21, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex:BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer, Michael D. West, Ph.D., will present...

March 21, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--ConforMIS, Inc. filed documents to initiate an interference proceeding in the United States Patent and Trademark Office involving a patent application held by Imperial Innovations Group.

March 21, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.ob - News), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce its acquisition of The Kaneabis Brand through its parent...

March 21, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Freshmedx announced its study on the use of computed biconductance technology in detecting lung cancer will be published in the April 2012 Journal of Thoracic Oncology.

March 21, 2012

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Shareholders in Moberg Derma AB (publ) (reg. no. 556697-7426) (the “Company”) are hereby convened to the Annual General Meeting on Monday, April 23, 2012 at 5:30 p.m. in the Company´s premises...

March 21, 2012

AMSTERDAM--(BUSINESS WIRE)--BIO-Europe Spring® 2013 to be held in Barcelona

March 21, 2012

LONDON & AMSTERDAM--(BUSINESS WIRE)--Novel EUR 150 million collaborative investment announced at BIO-Europe Spring® 2012 in Amsterdam

March 21, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue,...

March 21, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it is transferring the listing of its American Depositary Shares (“ADSs”), each representing one ordinary share of Teva common stock, to the New...

March 21, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced additional analyses from the ARISTOTLE and AVERROES clinical trials will be presented at the American College of...

March 21, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that Nancy A. Simonian, M.D. has been appointed to the company’s Board of Directors. Dr. Simonian is a biotechnology veteran with more than 16 years of global...